|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.080 USD | +0.25% |
|
+4.21% | +102.99% |
| 06-18 | Chardan Raises Price Target on Opus Genetics to $13 From $11, Keeps Buy Rating | MT |
| 06-16 | Opus Genetics, Inc. - Special Call |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.25% | +4.21% | -4.23% | -7.06% | +102.99% | +329.43% | +0.49% | -14.29% | - | 331M | |
| +0.32% | -2.41% | +3.48% | +21.55% | +2.55% | +44.49% | +140.80% | +397.69% | +1,408.25% | 980B | |
| +1.27% | -1.85% | -1.30% | -1.73% | +11.76% | +54.41% | +39.65% | +41.36% | +98.60% | 550B | |
| +6.25% | +3.80% | +6.63% | +12.16% | +0.67% | +24.13% | +67.39% | +100.53% | +280.87% | 382B | |
| +0.25% | -1.93% | -4.39% | +6.28% | -2.56% | +23.33% | +16.35% | -7.38% | +29.84% | 316B | |
| +0.42% | +0.68% | -4.50% | -4.36% | -3.63% | +27.89% | +14.57% | +59.16% | +241.91% | 272B | |
| +1.67% | +0.05% | +0.69% | +4.05% | +9.74% | +26.76% | +33.56% | +40.20% | +56.51% | 268B | |
| +2.39% | +5.02% | +3.79% | +26.32% | -7.78% | -36.96% | -44.76% | +16.87% | +72.53% | 199B | |
| +2.11% | -1.66% | +1.60% | -0.89% | +5.32% | +19.14% | +50.10% | +43.69% | +130.10% | 182B | |
| +0.90% | +0.46% | -7.06% | -8.99% | +1.74% | +15.09% | +59.86% | +86.23% | +51.45% | 154B | |
| -0.52% | -3.54% | -3.17% | -7.01% | +0.72% | +4.63% | -35.24% | -36.68% | -27.24% | 144B | |
| +3.36% | +3.63% | +7.43% | +2.82% | +2.96% | +5.88% | +34.07% | +147.15% | +447.75% | 115B | |
| +1.30% | -2.74% | -8.01% | -4.84% | +1.41% | +16.73% | -16.23% | -17.05% | -24.35% | 110B | |
| -2.23% | -4.04% | -5.71% | -6.81% | -12.37% | -12.89% | -25.74% | -17.37% | +1.85% | 102B | |
| -0.05% | -1.71% | +0.50% | -1.33% | +5.48% | +37.22% | +41.61% | +10.38% | +8.46% | 101B | |
| +0.01% | 0.00% | -7.32% | -5.34% | -8.73% | +0.17% | +78.23% | +72.98% | +521.74% | 77.05B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| +0.90% | 0.00% | -1.65% | -9.99% | +3.83% | +17.18% | +9.18% | +34.48% | +12.91% | 48.34B | |
| +1.94% | +3.09% | -2.20% | -10.48% | -17.14% | -4.64% | +6.38% | -29.97% | +234.57% | 47.32B | |
| +0.90% | +5.15% | -0.86% | -0.53% | +3.16% | +43.08% | -24.40% | -25.58% | -58.43% | 42.64B | |
| Average | +1.04% | -0.51% | -1.38% | +0.20% | +5.27% | +33.42% | +23.47% | +47.50% | +193.74% | 207.69B | |
| Weighted average by Cap. | +1.29% | -2.24% | +0.24% | +6.58% | +2.08% | +27.26% | +53.16% | +125.58% | +433.45% |
- Stock Market
- Stocks
- IRD Stock
- Sector Opus Genetics, Inc.
Select your edition
All financial news and data tailored to specific country editions
